Skip to content

Built to deliver uncommon insight.

Home
Team
Events
Contact
Ratings
Research

Chugai Pharm. (4519, Neutral): Looking beyond 1H results: Actemra facing new competition; ACE-910 and atezolizumab to drive growth, but valuations appear to discount it

Policy on Independence | Terms of Business | Privacy Policy

New Street Research LLP is registered in England and Wales No. OC303987. Registered office: 52 Cornhill, London, EC3V 3PD. New Street Research LLP is authorised and regulated in the conduct of its designated investment business in the United Kingdom by the Financial Conduct Authority.

© New Street Research LLP.
All Rights Reserved.
New Street Research, 52 Cornhill, London, EC3V 3PD

+44 20 7375 9111
info@newstreetresearch.com

Proudly powered by WordPress

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok